Consolidated Biosciences ApS: Financial statements 2021
CVR: 40180230
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Consolidated Biosciences ApS (CVR 40180230) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -33,750 and a net result of DKK -1,086,215 compared with DKK -584,728 the year before. Equity in the 2021 report amounted to DKK -1,020,795.
- Gross Profit
- DKK -33,750
- Profit/Loss
- DKK -1,086,215
- Equity
- DKK -1,020,795
- Total Assets
- DKK 52,437,657
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -34K | -1.1M | -1M | - |
| 2020 | - | -43K | -585K | 65K | - |
| 2019 | - | -25K | -430K | 50K | - |
Official annual report
Find more companies like Consolidated Biosciences ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
Consolidated Biosciences ApS has published its annual report for 2020. Gross profit came to DKK -43,000, and the net result was DKK -584,728.
About Consolidated Biosciences ApS
Consolidated Biosciences ApS is a Danish company of the type Anpartsselskab based in Vedbæk, founded in 2019. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Lone Schøtt Kunøe. The company is owned by CENTRAL EUROPEAN FOOD PRODUCTION COMPANY ApS, CONSOLIDATED HOLDINGS A/S and L1 HOLDING ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -52,501 and a net result of DKK -1,814,488 compared with DKK -1,740,301 the year before. Equity in the 2025 report amounted to DKK 202,862.